Design, development and in vitro evaluation of sennosides tablets containing pectin HPMC for colonic drug delivery

Indian Journal of Pharmaceutical Sciences

Volumn 69, Issue 3, 2007, Pages 394-401

  Momin, Munira ^a   Pundarikakshudu, K ^a  

^a LJ Institute of Pharmacy and Research Center Ahmedabad   (India)

Author keywords

Calcium sennoside; Colonic delivery; Compression coating; Pectinase enzyme; Roentegenography

Indexed keywords

BUFFER; CALCIUM SENNOSIDE; HYDROXYPROPYLMETHYLCELLULOSE; PECTIN; PHOSPHATE; SENNOSIDE; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUBILITY; FACTORIAL DESIGN; GASTROINTESTINAL TRANSIT; HUMAN; NORMAL HUMAN; PH; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; X RAY; X RAY PICTURE;

EID: 34548501325     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0250-474x.34549     Document Type: Article

References (16)

1. Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci 2003;6:33-66.
2. Rubinstein A, Radai R. In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur J Pharm Biopharm 1995;41:291-5.
3. Wakerly Z, Fell J, Attwood D, Perkins D. Studies on drug release from pectin/ethylcellulose film coated tablets: A potential colonic delivery system. Int J Pharm 1997;153:219-24.
4. Sriamornsak P. Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads. Int J Pharm 1998;169:213-20.
5. Macleod G, Collett J, Fell J. The potential use of mixed films of pectin, Chitosan and HPMC for bimodal drug release. J Control Release 1999;58:303-10.
6. Turkoglu M, Takka SD, Baran H, Sakr A. Pectin hydroxymethyl cellulose drug delivery system for colon targeting. Pharm Ind 1999;61:662-5.
7. Fairbairn JW. The active constituents of the vegetable purgatives containing anthracene derivatives. J Pharm Pharmacol 1949;1:683-6.
8. Franz G. The Senna drug and its chemistry, Pharmacology 1993;47:2-6.
9. nd ed. London; Royal Pharmaceutical Society: 1996. p. 1212.
10. Munira M, Pundarikakshudu K. Studies on the development and optimization of oral colon targeted drug delivery system for sennoside in the treatment of constipation. Drug Delivery Technol 2004;6:71-7.
11. Munira M, Pundarikakshudu K. Studies on formulation development of colon targeted drug delivery system for sennosides. J Pharm Pharma Sci. Available from: http://www.ualberta.ca/~csps/JPPS7/Issue7(3).htm. [Last updated on 2004 Dec].
12. rd ed. New York; Marcel Dekker Inc.: 1997. p. 326.
13. Turkoglu M, Timucin U. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm 2002;53:65-73.
14. th ed. British pharmacopoeia commission. Health ministry. London; 1993. p. 592.
15. Munira M, Pundarikakshudu K. Optimization and pharmacotechnical evaluation of compression coated colon specific drug delivery system of Triphala using factorial design, Drug Dev Res 2005;65:34-42.
16. Wallace H., Steinberg GH, Josheph N, Hasting H. Methods for determining in vivo tablet disintegration. J Pharm Sci 1965;54:747-52.